100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothPrazosin 2.5mg
You Searched
Prazopress XL 2.5mg Tablet OPS 30s
Sun Pharmaceutical Industries Ltd.
₹407.8
Our Recommendation
Biozocin 2.5mg XL Tablet 15s
4,462+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Hypertension (high blood pressure) / Treatment of Heart failure
Customers also bought
More About Prazopress XL 2.5mg Tablet OPS 30s
Benefits
In Treatment of Hypertension (high blood pressure) Prazopress XL 2.5 Tablet OPS works by relaxing your blood vessels and making it easier for your heart to pump blood around your body. This lowers blood pressure. If your blood pressure is controlled, you are less at risk of having a heart attack, stroke, or kidney problems. The medicine must be taken regularly as prescribed to be effective. You may not feel the immediate benefit after taking the medicine, however, it works in the long term to keep you well. In Treatment of Heart failure Prazopress XL 2.5 Tablet OPS is usually used in the treatment of heart failure when other medicines are no longer working or have not worked at all. It works by relaxing your blood vessels and making it easier for your heart to pump blood around your body. The medicine improves your heart function and helps reduce the symptoms of congestion. To get the most benefits from the medicine, it should be taken regularly and as long as the doctor has prescribed it.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How it works
Prazopress XL 2.5 Tablet OPS is an alpha blocker. It lowers blood pressure by relaxing blood vessels so that blood can flow more easily through the body.
Unsafe: Avoid consuming alcohol with Prazopress XL 2.5 Tablet OPS as it is deemed unsafe.
Seek medical advice from your doctor: Prazopress XL 2.5 Tablet OPS may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Prazopress XL 2.5 Tablet OPS is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Prazopress XL 2.5 Tablet OPS may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Prazopress XL 2.5 Tablet OPS is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Prazopress XL 2.5 Tablet OPS may not be needed in these patients. Doctor consultation is advised. Prazopress XL 2.5 Tablet OPS may be started with a low dose and then increased further. Regular blood pressure monitoring is advisable for dose adjustment.
Caution Advised: Prazopress XL 2.5 Tablet OPS should be used with caution in patients with liver disease. Dose adjustment of Prazopress XL 2.5 Tablet OPS may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Prazopress XL 2.5 Tablet OPS is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
References
Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 305-308
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1145-46
Robertson D, Biaggioni I. Adrenoreceptor Antagonists Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 152
Prazosin hydrochloride (25 Jan. 2019)
Prazosin (04 Apr. 2019)
Prazosin (04 Apr. 2019)
Basquez R, Pippin MM. Prazosin (04 Aug. 2023)
Central Drugs Standard Control Organisation. Prazosin (05 Aug. 2023)
Prazosin Hydrochloride (24 Apr. 2025)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
